Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Arjo

31.80 SEK

+0.06 %

Less than 1K followers

ARJO B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+0.06 %
+2.98 %
-6.08 %
+0.25 %
-12.30 %
-8.20 %
-26.22 %
-47.22 %
+29.11 %

Arjo operates in the medical technology industry and focuses on the development, manufacture and distribution of medical equipment for patient management and rehabilitation. The company's products are aimed at healthcare institutions and nursing homes. The business is global with a main presence in Europe, North America and Asia. Arjo was founded in 1957 and is headquartered in Malmö, Sweden.

Read more
Market cap
8.66B SEK
Turnover
19.2M SEK
Revenue
11.29B
EBIT %
7.91 %
P/E
17.38
Dividend yield-%
2.99 %
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
30/1
2026

Annual report '25

29/4
2026

General meeting '26

29/4
2026

Interim report Q1'26

All
Webcasts
Press releases
ShowingAll content types
Arjo, Audiocast, Q3'25
Webcast10/22/2025, 6:00 AM

Arjo, Audiocast, Q3'25

Arjo
Regulatory press release10/22/2025, 5:00 AM

Arjos delårsrapport för januari-september 2025

Arjo
Regulatory press release10/22/2025, 5:00 AM

Arjo's interim report January-September 2025

Arjo

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release9/29/2025, 9:45 AM

Arjo publicerar datum för delårsrapport januari-september 2025 och bjuder in till telefonkonferens

Arjo
Press release9/29/2025, 9:45 AM

Arjo announces date for 2025 Q3 and conference call

Arjo
Regulatory press release8/28/2025, 6:30 AM

Christofer Carlsson utsedd till permanent CFO för Arjo

Arjo
Regulatory press release8/28/2025, 6:30 AM

Christofer Carlsson appointed permanent CFO of Arjo

Arjo
Regulatory press release8/25/2025, 9:25 AM

Tillträdande VD i Arjo har förvärvat syntetiska köpoptioner i Arjo

Arjo
Regulatory press release8/25/2025, 9:25 AM

Incoming CEO of Arjo has acquired synthetic call options in Arjo

Arjo
Regulatory press release7/30/2025, 6:00 AM

Andréas Elgaard appointed new President and CEO of Arjo

Arjo
Regulatory press release7/30/2025, 6:00 AM

Andréas Elgaard utsedd till ny VD och koncernchef för Arjo

Arjo
Regulatory press release7/21/2025, 6:00 AM

Niclas Sjöswärd leaving the position as interim President and CEO of Arjo

Arjo
Regulatory press release7/21/2025, 6:00 AM

Niclas Sjöswärd lämnar uppdraget som tillförordnad VD och koncernchef för Arjo

Arjo
Arjo, Audiocast, Q2'25
Webcast7/11/2025, 6:00 AM

Arjo, Audiocast, Q2'25

Arjo
Regulatory press release7/11/2025, 5:00 AM

Arjo's interim report January-June 2025

Arjo
Regulatory press release7/11/2025, 5:00 AM

Arjos delårsrapport för januari-juni 2025

Arjo
Regulatory press release6/24/2025, 12:00 PM

Arjo publicerar datum för delårsrapport januari-juni 2025 och bjuder in till telefonkonferens

Arjo
Regulatory press release6/24/2025, 12:00 PM

Arjo announces date for 2025 Q2 and conference call

Arjo
Regulatory press release4/29/2025, 5:00 PM

Beslut vid Arjos årsstämma 2025

Arjo
Regulatory press release4/29/2025, 5:00 PM

Resolutions at Arjo's Annual General Meeting 2025

Arjo
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.